Dot blots of solubilized extracellular matrix allow quantification of human antibodies bound to epitopes present in decellularized porcine pulmonary heart valves.
antibody
decellularization
preformed antibodies
solubilized ECM
xenoantigen
xenotransplantation
Journal
Xenotransplantation
ISSN: 1399-3089
Titre abrégé: Xenotransplantation
Pays: Denmark
ID NLM: 9438793
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
07
04
2020
revised:
13
08
2020
accepted:
02
09
2020
pubmed:
19
9
2020
medline:
18
9
2021
entrez:
18
9
2020
Statut:
ppublish
Résumé
The present study reports the development of a sensitive dot blot protocol for determining the level of preformed antibodies against porcine heart valve tissue derived from wild-type (WT) and α-Gal-KO (GGTA1-KO) pigs in human sera. The assay uses decellularized and solubilized heart valve tissue; antibody binding found in this dot blot assay could be correlated with antibody titers of preformed anti-α-Gal and anti-Neu5Gc antibodies detected by a sensitive ELISA. The ultimate protocol had an inter-assay variance of 9.5% and an intra-assay variance of 9.2%, showing that the test is reliable and highly reproducible. With the aid of this dot blot assay, we found significant variation with regard to antibody contents among twelve human sera. Binding of preformed antibodies to WT tissue was significantly higher than to GGTA1-KO tissue. The dot blot assay described herein could be a valuable tool to measure preformed antibody levels in human sera against unknown epitopes on decellularized tissue prior to implantation. Ultimately, this prescreening may allow a matching of the porcine xenograft with the respective human recipients in demand and thus may become an important tool for graft long-term survival similar to current allotransplantation settings.
Sections du résumé
BACKGROUND
The present study reports the development of a sensitive dot blot protocol for determining the level of preformed antibodies against porcine heart valve tissue derived from wild-type (WT) and α-Gal-KO (GGTA1-KO) pigs in human sera.
METHODS
The assay uses decellularized and solubilized heart valve tissue; antibody binding found in this dot blot assay could be correlated with antibody titers of preformed anti-α-Gal and anti-Neu5Gc antibodies detected by a sensitive ELISA.
RESULTS
The ultimate protocol had an inter-assay variance of 9.5% and an intra-assay variance of 9.2%, showing that the test is reliable and highly reproducible. With the aid of this dot blot assay, we found significant variation with regard to antibody contents among twelve human sera. Binding of preformed antibodies to WT tissue was significantly higher than to GGTA1-KO tissue.
CONCLUSIONS
The dot blot assay described herein could be a valuable tool to measure preformed antibody levels in human sera against unknown epitopes on decellularized tissue prior to implantation. Ultimately, this prescreening may allow a matching of the porcine xenograft with the respective human recipients in demand and thus may become an important tool for graft long-term survival similar to current allotransplantation settings.
Substances chimiques
Epitopes
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12646Informations de copyright
© 2020 The Authors. Xenotransplantation published by John Wiley & Sons Ltd.
Références
Sarikouch S, Horke A, Tudorache I, et al. Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience. Eur J Cardiothorac Surg. 2016;50(2):281-290.
Boethig D, Horke A, Hazekamp M, et al. A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR trial and ESPOIR registry datadagger. Eur J Cardiothorac Surg. 2019;56(3):503-509.
Siebelink MJ, Albers MJ, Roodbol PF, Van de Wiel HB. Children as donors: a national study to assess procurement of organs and tissues in pediatric intensive care units. Transpl Int. 2012;25(12):1268-1274.
Platt J. Recommendations of the national heart, lung, and blood institute heart and lung xenotransplantation working group. Circulation. 2002;106(9):1043-1047.
Petersen B, Carnwath JW, Niemann H. The perspectives for porcine-to-human xenografts. Comp Immunol Microbiol Infect Dis. 2009;32(2):91-105.
Niemann H, Petersen B. The production of multi-transgenic pigs: update and perspectives for xenotransplantation. Transgenic Res. 2016;25(3):361-374.
Langin M, Mayr T, Reichart B, et al. Consistent success in life-supporting porcine cardiac xenotransplantation. Nature. 2018;564(7736):430-433.
Griffiths LG, Choe LH, Reardon KF, Dow SW, Christopher OE. Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials. 2008;29(26):3514-3520.
Roderjan JG, de Noronha L, Stimamiglio MA, et al. Structural assessments in decellularized extracellular matrix of porcine semilunar heart valves: evaluation of cell niches. Xenotransplantation. 2019;26(3):e12503.
Kasimir MT, Rieder E, Seebacher G, et al. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis. 2006;15(2):278-86.
Ramm R, Niemann H, Petersen B, Haverich A, Hilfiker A. Decellularized GGTA1-KO pig heart valves do not bind preformed human xenoantibodies. Basic Res Cardiol. 2016;111(4):39.
Findeisen K, Morticelli L, Goecke T, et al. Toward acellular xenogeneic heart valve prostheses: histological and biomechanical characterization of decellularized and enzymatically deglycosylated porcine pulmonary heart valve matrices. Xenotransplantation. 2020:e12617. https://doi.org/10.1111/xen.12617 [Epub ahead of print].
Perri G, Polito A, Esposito C, et al. Early and late failure of tissue-engineered pulmonary valve conduits used for right ventricular outflow tract reconstruction in patients with congenital heart disease. Eur J Cardiothorac Surg. 2012;41(6):1320-1325.
Simon P, Kasimir M-T, Seebacher G, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT™ in pediatric patients. Eur J Cardiothorac Surg. 2003;23(6):1002-1006.
Akhyari P, Minol P, Assmann A, Barth M, Kamiya H, Lichtenberg A. Tissue engineering of heart valves. Chirurg. 2011;82(4):311-318.
Boer U, Schridde A, Anssar M, et al. The immune response to crosslinked tissue is reduced in decellularized xenogeneic and absent in decellularized allogeneic heart valves. Int J Artif Organs. 2015;38(4):199-209.
Daugs A, Lehmann N, Eroglu D, Meinke MC, Markhoff A, Bloch O. In vitro detection system to evaluate the immunogenic potential of xenografts. Tissue Eng Part C Methods. 2018;24(5):280-288.
Long C, Lee W, Zhang ZQ, et al. Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans. PLoS One. 2017;12(7):e0180768.
Chen G, Qian H, Starz T, et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med. 2005;11(12):1295-1298.
Galili U. Induced anti-non gal antibodies in human xenograft recipients. Transplantation. 2012;93(1):11-16.